The First
The Best
The Frontier of Early Cancer Dx
Innovating MDx with IPs
HeimBiotek developed a highly accurate molecular diagnostic technique for diagnosis of early to late-stage cancer with liquid biopsy using whole blood, urine etc. based on miRNA detection and analysis technology, ahead of its commercialization.
Global
Innovation
R&D Initiatives & Advancement
For Global Leadership in MDx
Driving R&D and Innovation to address the unmet needs of Liquid Biopsy Cancer Diagnostics, starting with Liver Cancer.
MicroRNA
miRNA Biomarker
Next-Generation Biomarker for Early Dx Introducing an innovative diagnostic methodfor Cancer, Encephalopathy, Cardiovascular Diseases etc.
![](https://heimbiotek.com/wp-content/uploads/2024/03/logo_trans2.png)
Technology
miRNA Detection
Detection and analyzing method to quantify the miRNA by using Real-time PCR and demonstrates high sensitivity and accuracy.
![](https://heimbiotek.com/wp-content/uploads/2024/03/logo_trans2.png)
Products
Based on Detection & Analysis of miRNA
Discover innovative solutions that use cutting-edge miRNA technology to address the unmet needs of MDx.